BlackRock Health Sciences Trust (NYSE:BME) Sees Large Decline in Short Interest

BlackRock Health Sciences Trust (NYSE:BME) was the recipient of a large decline in short interest during the month of November. As of November 30th, there was short interest totalling 6,200 shares, a decline of 56.0% from the November 15th total of 14,100 shares. Based on an average daily trading volume, of 38,100 shares, the short-interest ratio is presently 0.2 days.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Fountainhead AM LLC purchased a new stake in BlackRock Health Sciences Trust in the third quarter valued at approximately $204,000. Calamos Advisors LLC boosted its holdings in shares of BlackRock Health Sciences Trust by 46.4% in the 2nd quarter. Calamos Advisors LLC now owns 7,884 shares of the company’s stock valued at $322,000 after acquiring an additional 2,500 shares during the last quarter. City of London Investment Management Co. Ltd. acquired a new stake in shares of BlackRock Health Sciences Trust in the second quarter worth $429,000. Logan Stone Capital LLC purchased a new position in shares of BlackRock Health Sciences Trust during the second quarter worth $600,000. Finally, International Assets Investment Management LLC acquired a new position in BlackRock Health Sciences Trust during the third quarter valued at $8,610,000.

BlackRock Health Sciences Trust Price Performance

NYSE:BME opened at $38.68 on Friday. BlackRock Health Sciences Trust has a 52 week low of $38.00 and a 52 week high of $42.86. The firm has a 50 day moving average of $40.31 and a 200 day moving average of $40.84.

BlackRock Health Sciences Trust Announces Dividend

The business also recently disclosed a monthly dividend, which will be paid on Monday, December 23rd. Investors of record on Monday, December 16th will be given a $0.2621 dividend. This represents a $3.15 annualized dividend and a dividend yield of 8.13%. The ex-dividend date is Monday, December 16th.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.